By using DiabetesTimes.co.uk, you agree to our terms and use of cookies to enhance your experience.

Pioglitazone and Bladder Cancer

Title
Pioglitazone and Bladder Cancer
Type
Position statement
Category
Medication
Produced by
Diabetes UK
Summary
A position statement on the link between pioglitazone and bladder cancer, following the European Medicines Agency (EMA) safety review of the drug using all the available data from preclinical studies, the PROactive study (1) and population-based studies.
Date of publication
2011
Link
To access the resource, click here.